3rd Quarter - Report
ADVANCED POLICY CONSULTING, LLC for BRISTOL-MYERS SQUIBB COMPANY
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education regarding CMSs Initial Price Applicability Year (IPAY) 2029 proposed rule regarding the fixed-dose combination policy which would create significant disincentives for research and development, undermine FDA-recognized distinctions between therapies, and limit patient access to critical treatment options.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW MCGINLEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.